Krystal Biotech, Inc. KRYS Operating Income
Operating Income at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s operating income?
- Krystal Biotech, Inc. (KRYS) reported operating income of $53.69M in Q1 2026.
- How has Krystal Biotech, Inc.'s operating income changed year-over-year?
- Krystal Biotech, Inc.'s operating income increased by 48.1% year-over-year, from $36.25M to $53.69M.
- What is the long-term trend for Krystal Biotech, Inc.'s operating income?
- Over 4 years (2021 to 2025), Krystal Biotech, Inc.'s operating income has grown at a 24.0% compound annual growth rate (CAGR), from -$68.27M to $161.2M.
- What does operating income mean?
- Profit earned from core business operations before interest and taxes.
- How do you interpret operating income?
- An increase signals improved profitability and operational efficiency, while a decrease suggests margin compression or rising costs.
- How does operating income compare across companies?
- A universal measure of operational performance used to compare companies within and across industries.